Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Abraham,
Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
2010, Pubmed
Abraham,
Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
2010,
Pubmed
Agafonova,
Influence of cucumariosides upon intracellular [Ca2+]i and lysosomal activity of macrophages.
2003,
Pubmed
,
Echinobase
Aminin,
Antitumor activity of the immunomodulatory lead Cumaside.
2010,
Pubmed
,
Echinobase
Aminin,
Anticancer activity of sea cucumber triterpene glycosides.
2015,
Pubmed
,
Echinobase
Donenko,
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil.
1991,
Pubmed
Dyshlovoy,
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
2016,
Pubmed
Endicott,
The biochemistry of P-glycoprotein-mediated multidrug resistance.
1989,
Pubmed
Ford,
Pharmacology of drugs that alter multidrug resistance in cancer.
1990,
Pubmed
Glavinas,
Calcein assay: a high-throughput method to assess P-gp inhibition.
2011,
Pubmed
Jain,
Reversal of P-glycoprotein-mediated multidrug resistance by sipholane triterpenoids.
2007,
Pubmed
Kalinin,
Hemolytic activities of triterpene glycosides from the holothurian order Dendrochirotida: some trends in the evolution of this group of toxins.
1996,
Pubmed
,
Echinobase
Menchinskaya,
Antitumor activity of cucumarioside A2-2.
2013,
Pubmed
,
Echinobase
Menchinskaya,
Inhibition of tumor cells multidrug resistance by cucumarioside A2-2, frondoside A and their complexes with cholesterol.
2013,
Pubmed
,
Echinobase
Nielsen,
Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.
1994,
Pubmed
Nielsen,
P-glycoprotein expression in Ehrlich ascites tumour cells after in vitro and in vivo selection with daunorubicin.
1998,
Pubmed
Osman,
Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line.
2012,
Pubmed
Reunov,
Cucumarioside A2-2 stimulates apoptotic necrosis in Ehrlich ascites carcinoma cells.
2015,
Pubmed
Shen,
Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
2008,
Pubmed
